Oncogenic role and therapeutic targeting of ABL-class and JAK-STAT activating kinase alterations in Ph-like ALL.

Roberts, Kathryn G; Yang, Yung-Li; Payne-Turner, Debbie; Lin, Wenwei; Files, Jacob K; Dickerson, Kirsten; Gu, Zhaohui; Taunton, Jack; Janke, Laura J; Chen, Taosheng; Loh, Mignon L; Hunger, Stephen P; Mullighan, Charles G.

Afiliación

Roberts KG; Department of Pathology and.
Yang YL; Department of Pathology and.
Payne-Turner D; Department of Pathology and.
Lin W; Department of Chemical Biology and Therapeutics, St. Jude Children's Research Hospital, Memphis, TN.
Files JK; Department of Pathology and.
Dickerson K; Department of Pathology and.
Gu Z; Integrated Biomedical Sciences Program, University of Tennessee Health Science Center, Memphis, TN.
Taunton J; Department of Pathology and.
Janke LJ; Department of Cellular and Molecular Pharmacology.
Chen T; Department of Pathology and.
Loh ML; Department of Chemical Biology and Therapeutics, St. Jude Children's Research Hospital, Memphis, TN.
Hunger SP; Department of Pediatrics, UCSF Benioff Children's Hospital, and.
Mullighan CG; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA; and.

Blood Adv ; 1(20): 1657-1671, 2017 Sep 12.

Article en En | MEDLINE | ID: mdl-29296813

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: Blood Adv Año: 2017 Tipo del documento: Article

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: Blood Adv Año: 2017 Tipo del documento: Article